Echocardiographic Evaluation of Right Ventricular Systolic Function and Right Ventricle–Pulmonary Artery Coupling In Patients With Chronic Obstructive Pulmonary Disease

Autores

Resumo

Abstract

Chronic obstructive pulmonary disease (COPD), in addition to causing airflow limitation, is associated with cardiovascular changes, including right ventricular (RV) dysfunction due to increased pressure resistance in the pulmonary circulation. This study aimed to assess RV function in patients with COPD using echocardiographic indices of systolic function and a non-invasive measurement of ventriculo-arterial coupling, as well as its association with functional outcomes. it was a transversal observational study. The study included patients who had spirometric diagnosis of COPD. Fifty-eight patients participated in the study (53.4% male, n = 31) mean age 65 years (SD = 8.7). Tricuspid annular plane systolic excursion (TAPSE), RV tissue S’ wave velocity and TAPSE/PSAP (pulmonary artery systolic pressure) were significantly impaired according to degree of airflow obstruction progression [p = 0.01; p = 0.02, and p = 0.03], respectively. There was significantly lower predicted forced Expiratory Volume in one second (FEV1) compared with the occurrence of two or more abnormal index of RV function versus one or no abnormality (36.4 vs 49.7; p = 0.02). The mean value for TAPSE/PSAP was 0.82 mm/mmHg. RV systolic function impairment was present in a significant proportion of COPD patients despite no clinical suspicion. Lower values of noninvasively determined RVPA coupling were related with lower predicted FEV1 and worse clinical status and can be a promising tool for the estimation of RV deterioration in COPD patients.

Keywords: Pulmonary Disease, Chronic Obstructive. Right Ventricular-Arterial Coupling. Echocardiography.

Resumo

A doença pulmonar obstrutiva crônica (DPOC), além de causar limitação ao fluxo aéreo, está associada a alterações cardiovasculares, incluindo disfunção do ventrículo direito (VD) devido ao aumento da resistência na circulação pulmonar. O objetivo deste estudo foi avaliar a função do ventrículo direito (VD) em pacientes com DPOC, utilizando índices ecocardiográficos de função sistólica e medida não invasiva do acoplamento ventrículo-arterial, bem como sua associação com repercussões funcionais. Estudo observacional transversal. O estudo incluiu pacientes que tinham diagnóstico espirométrico de DPOC. Cinquenta e oito pacientes participaram do estudo (53,4% do sexo masculino, n = 31) com média de idade de 65 anos (DP = 8,7). A excursão sistólica do plano anular tricúspide (TAPSE), a velocidade da onda S' do tecido do VD e a TAPSE/PSAP (pressão sistólica da artéria pulmonar) foram significativamente prejudicadas de acordo com o grau de progressão da obstrução ao fluxo aéreo [p = 0,01; p = 0,02, e p = 0,03], respectivamente. O volume expiratório forçado previsto em um segundo (FEV1) foi significativamente menor em comparação com a ocorrência de dois ou mais índices anormais da função do VD em comparação com uma ou nenhuma anormalidade (36,4 vs 49,7; p = 0,02). O valor médio para TAPSE/PSAP foi 0,82 mm/mmHg. O comprometimento da função sistólica do VD estava presente em uma proporção significativa de pacientes com DPOC, apesar da ausência de suspeita clínica. Os valores mais baixos do acoplamento VD-AP determinado de forma não invasiva foram relacionados a um FEV1 previsto mais baixo e a um pior estado clínico e podem ser uma ferramenta promissora para a estimativa da deterioração do VD em pacientes com DPOC.

Palavras-chave: Doença Pulmonar Obstrutiva Crônica. Acoplamento Ventricular Direitoarterial. Ecocardiografia

Downloads

Não há dados estatísticos.

Referências

Hilde JM, Skjørten I, Grøtta OJ, Hansteen V, Melsom MN, Hisdal J, Humerfelt S, Steine K. Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension. J Am Coll Cardiol. 2013;62(12):1103-1111. doi: 10.1016/j.jacc.2013.04.091.

Agustí A, Hogg JC. Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease. N Engl J Med. 2019;381(13):1248-1256. doi: 10.1056/NEJMra1900475.

Vogelmeier C, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Criner G, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2023 [cited 2022 Dec 1]. Available from: https://goldcopd.org/2023-gold-report-2.

Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, et al. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2018;137(20):e578-e622. doi: 10.1161/CIR.0000000000000560.

Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography. J Am Soc Echocardiogr. 2010; 23:685-713. [cited 2023 Oct 10]. Available from: Available from: https://www.asecho.org/wp-content/uploads/2014/01/RV_Portuguese.pdf

Smolarek D, Gruchała M, Sobiczewski W. Echocardiographic evaluation of right ventricular systolic function: The traditional and innovative approach. Cardiol J. 2017;24(5):563-572. doi: 10.5603/CJ.a2017.0051.

Guazzi M. The alarming association between right ventricular dysfunction and outcome: aetiology matters. Eur Heart J. 2020;41(12):1283-1285. doi: 10.1093/eurheartj/ehaa080.

Padang R, Chandrashekar N, Indrabhinduwat M, Scott CG, Luis SA, Chandrasekaran K, et al. Aetiology and outcomes of severe right ventricular dysfunction. Eur Heart J. 2020;41(12):1273-1282. doi: 10.1093/eurheartj/ehaa037.

Sanz J, García-Alvarez A, Fernández-Friera L, Nair A, Mirelis JG, Sawit ST, et al. Right ventricle-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart. 2012;98(3):238-43. doi: 10.1136/heartjnl-2011-300462.

Llucià-Valldeperas A, de Man FS, Bogaard HJ. Adaptation and Maladaptation of the Right Ventricle in Pulmonary Vascular Diseases. Clin Chest Med. 2021;42(1):179-194. doi: 10.1016/j.ccm.2020.11.010.

Tello K, Wan J, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, et al. Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension. Circ Cardiovasc Imaging. 2019;12(9):e009047. doi: 10.1161/CIRCIMAGING.119.009047.

Richter MJ, Yogeswaran A, Husain-Syed F, Vadász I, Rako Z, Mohajerani E, et al. A novel non-invasive and echocardiography-derived method for quantification of right ventricular pressure-volume loops. Eur Heart J Cardiovasc Imaging. 2022;23(4):498-507. doi: 10.1093/ehjci/jeab038.

Todaro MC, Carerj S, Zito C, Trifirò MP, Consolo G, Khandheria B. Echocardiographic evaluation of right ventricular-arterial coupling in pulmonary hypertension. Am J Cardiovasc Dis. 2020;10(4):272-283.

Bragança B, Trêpa M, Santos R, Silveira I, Fontes-Oliveira M, Sousa MJ, et al. Echocardiographic Assessment of Right Ventricle-arterial Coupling: Clinical Correlates and Prognostic Impact in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy. J Cardiovasc Imaging. 2020;28(2):109-120. doi: 10.4250/jcvi.2019.0094.

Silva GP, Morano MT, Viana CM, Magalhães CB, Pereira ED. Portuguese-language version of the COPD Assessment Test: validation for use in Brazil. J Bras Pneumol. 2013;39(4):402-8. doi: 10.1590/S1806-37132013000400002.

de Rê A, Fonseca FR, Queiroz AP, dos Reis CM, Bahl MM, Kocks J, et al. Versão brasileira do Clinical COPD Questionnaire, aplicado por meio de entrevista: propriedades de medida de confiabilidade e validade. J Bras Pneumol. 2021;47(3): e20200371. doi:org/10.36416/1806-3756/e20200371.

Cote CG, Casanova C, Marín JM, Lopez MV, Pinto-Plata V, de Oca MM, et al. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J. 2008;31(3):571-8. doi: 10.1183/09031936.00104507.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003.

Somayaji R, Chalmers JD. Just breathe: a review of sex and gender in chronic lung disease. Eur Respir Rev. 2022;31(163):210111. doi: 10.1183/16000617.0111-2021.

Burgess MI, Mogulkoc N, Bright-Thomas RJ, Bishop P, Egan JJ, Ray SG. Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease. J Am Soc Echocardiogr. 2002;15(6):633-9. doi:10.1067/mje.2002.118526.

Badano LP, Addetia K, Pontone G, Torlasco C, Lang RM, Parati G, et al. Advanced imaging of right ventricular anatomy and function. Heart. 2020;106(19):1469-1476. doi:10.1136/heartjnl-2019-315178.

Hamilton-Craig CR, Stedman K, Maxwell R, Anderson B, Stanton T, Chan J, et al. Accuracy of quantitative echocardiographic measures of right ventricular function as compared to cardiovascular magnetic resonance. Int J Cardiol Heart Vasc. 2016;12:38-44. doi: 10.1016/j.ijcha.2016.05.007.

Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D, et al. Unrecognised ventricular dysfunction in COPD. Eur Respir J. 2012;39(1):51-8. doi: 10.1183/09031936.00044411.

Schneider M, Aschauer S, Mascherbauer J, Ran H, Binder C, Lang I, et al.Echocardiographic assessment of right ventricular function: current clinical practice. Int JCardiovasc Imaging. 2019;35(1):49-56. doi: 10.1007/s10554-018-1428-8.

Fenster BE, Holm KE, Weinberger HD, Moreau KL, Meschede K, Crapo JD, et al. Right ventricular diastolic function and exercise capacity in COPD. Respir Med. 2015;109(10):1287-92. doi: 10.1016/j.rmed.2015.09.003.

Tannus-Silva DG, Masson-Silva JB, Ribeiro LS, Conde MB, Rabahi MF. Myocardial performance index correlates with the BODE index and affects quality of life in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016;11:2261-2268. doi: 10.2147/COPD.S110779.

Houben-Wilke S, Spruit MA, Uszko-Lencer NHMK, Otkinska G, Vanfleteren LEGW, Jones PW, et al. Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation. Respirology. 2017;22(5):928-934. doi: 10.1111/resp.12968.

Agusti A, Calverley PMA, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(1):122. doi: 10.1186/1465-9921-11-122.

Sepúlveda-Loyola W, Osadnik C, Phu S, Morita AA, Duque G, Probst VS. Diagnosis,prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2020;11(5):1164-1176. doi: 10.1002/jcsm.12600.

Neder JA, Berton DC, O'Donnell DE. Getting the most out of the six-minute walk test. JBras Pneumol. 2023;49(1):e20230028. doi: 10.36416/1806-3756/e20230028.

Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618-3731. doi:10.1093/eurheartj/ehac237.

Publicado

2025-03-28

Como Citar

1.
Martins AF, Fonseca FR, de Rê A, Martins D, Del Castanhel F, Maurici R. Echocardiographic Evaluation of Right Ventricular Systolic Function and Right Ventricle–Pulmonary Artery Coupling In Patients With Chronic Obstructive Pulmonary Disease. J. Health Sci. [Internet]. 28º de março de 2025 [citado 18º de junho de 2025];27(1):30-6. Disponível em: https://journalhealthscience.pgsscogna.com.br/JHealthSci/article/view/13678

Edição

Seção

Artigos

Artigos mais lidos pelo mesmo(s) autor(es)